Navinci at SITC 2023

Nov 2nd to 5th, San Diego, US

Navinci will attend SITC 2023 on Nov 2nd to 5th, San Diego, US. We will showcase our latest product designs and tell you what is new in protein-protein interaction technology. You can find us in the exhibition hall (booth 919) and at the scientific sessions with three poster presentations.

We would love to meet you, pleasebook a meeting with us!

Poster presentations

Fully automated in situ detection of protein-protein interactions in tissue
Abstract Number: 209
Date and Time: Friday Nov. 3 12–1:30 p.m. and 5:10–6:40 p.m
Fully automated in situ detection of protein-protein interactions in tissue (PDF)

New approaches to understanding the tumor microenvironment: in situ detection of immune checkpoint interactions in cancer patient tissue samples
Abstract Number: 210
Date and Time: Saturday Nov. 4 11:55–1:25 p.m. and 7–8:30 p.m.
New approaches to understanding the tumor microenvironment: in situ detection of immune checkpoint interactions in cancer patient tissue samples (PDF)

Investigating the E-Cadherin/β-catenin interaction in colon cancer: a proximity ligation approach
Abstract Number: 208
Date and Time: Saturday Nov. 4 11:55–1:25 p.m. and 7–8:30 p.m.
Investigating the E-Cadherin B-catenin interaction in colon cancer: a proximity ligation approach (PDF)

The Navinci Technology

Learn how to maximize information from every analysis by localizing and quantifying proteins, their interactions, and modifications in situ at a molecular level. In situ methods are commonly used in the cancer research field, and studies of protein-protein interactions (PPI) and protein translational modifications (PTM) are essential for: 

  • Deep biological knowledge 
  • Biomarker discovery 
  • Patient stratification 
  • Drug testing 
  • Treatment validation 

All our products are based on our proprietary Naveni® Proximity Ligation technology with dual antibody recognition giving you more specific and sensitive detection of your target of interest. Click here to read about the technology. 

To our flexible products – to use with your primary antibodies.

To our specific products – for the precise detection of PD1/PD-L1 interaction, and phosphorylated proteins PD1, Met, VEGFR2, EGFR, HER2, and PDGFR-beta.

PD1/PD-L1 news

We have some exciting developments to present at the SITC conference! We have continued the development of assays and tools to unravel the PD1 signaling pathways. As of today, we have several products and applications to detect and visualize PD1/PD-L1 interaction and signaling, read more here.

To know more, come to our booth 919.

Team Navinci at SITC 2023

We would love to meet you, pleasebook a meeting with us!

Robert Gunnarsson (CEO), Subham Basu (CBO), Lena Beckman (Marketing Manager), Tanja Bügsen (Area Manager Europe), Agata Zieba Wicher (CPSO), and Sara Twist (Field Marketing Manager).